Form 4: HealthEquity EVP, CHIEF TECHNOLOGY OFFICER Rosner Elimelech Reports Stock Disposal

Sentiment:

SEC Form 4 Filing


Elimelech Rosner, EVP, CHIEF TECHNOLOGY OFFICER of HealthEquity, Inc., reports the disposal of 52,078 shares of common stock to cover tax obligations.

Summary

  • On April 8, 2025, Elimelech Rosner, the EVP, CHIEF TECHNOLOGY OFFICER of HealthEquity, Inc., disposed of 52,078 shares of common stock.
  • The transaction was executed at a price of $79.8795 per share.
  • Following the transaction, Rosner directly owns 133,689 shares of HealthEquity, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions by an executive, indicating a neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the trading activities of company executives.

Stakeholder Impact

  • The transaction may have a minor impact on shareholders due to the change in ownership by a company executive, but it is unlikely to be significant.

Key Dates

DateDescription
07/07/2023Date of Power of Attorney filing by Mr. Rosner with the U.S. Securities and Exchange Commission.
04/08/2025Date of the transaction where 52,078 shares of common stock were disposed of.
04/10/2025Date of signature for the Form 4 filing.

Keywords

Form 4, HealthEquity, HQY, Elimelech Rosner, Stock Disposal, Beneficial Ownership, EVP, CHIEF TECHNOLOGY OFFICER

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.